Additionally, it has been suggested that the lack of ubiquitylation and the turnover of calcineurin A (CnA) activates cardiac hypertrophy through the NFAT (nuclear factor of activated T cells)-CnA signalling pathway, which is inhibited by MuRF1 [3]. The gene discussed is PPP3CA; the disease is cardiac hypertrophy.